In the study of the first recurrence of AML patients, AML cells were significantly characterized by increased levels of mitochondrial functional important proteins such as MRPL21 and MRPS37, which may guide treatment strategies to reduce the chemotherapeutic resistance to recurrent AML [23]. Here, CHCHD1 is linked to acute myeloid leukemia.